Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Roivant Sciences (ROIV) Operating Margin: 2020-2025

Historic Operating Margin for Roivant Sciences (ROIV) over the last 5 years, with Sep 2025 value amounting to -19,492.87%.

  • Roivant Sciences' Operating Margin fell 1185683.00% to -19,492.87% in Q3 2025 from the same period last year, while for Sep 2025 it was -7,005.04%, marking a year-over-year decrease of 2111591.00%. This contributed to the annual value of -3,453.32% for FY2025, which is 1720025.00% down from last year.
  • Latest data reveals that Roivant Sciences reported Operating Margin of -19,492.87% as of Q3 2025, which was down 48.46% from -13,130.05% recorded in Q2 2025.
  • Roivant Sciences' 5-year Operating Margin high stood at 32,948.56% for Q4 2023, and its period low was -19,492.87% during Q3 2025.
  • Over the past 3 years, Roivant Sciences' median Operating Margin value was -4,452.92% (recorded in 2024), while the average stood at -2,346.76%.
  • Per our database at Business Quant, Roivant Sciences' Operating Margin soared by 3,516,576bps in 2023 and then slumped by 3,599,115bps in 2024.
  • Quarterly analysis of 5 years shows Roivant Sciences' Operating Margin stood at -1,010.73% in 2021, then slumped by 120,647bps to -2,217.20% in 2022, then surged by 3,516,576bps to 32,948.56% in 2023, then plummeted by 3,599,115bps to -3,042.59% in 2024, then slumped by 1,185,683bps to -19,492.87% in 2025.
  • Its Operating Margin was -19,492.87% in Q3 2025, compared to -13,130.05% in Q2 2025 and -3,042.59% in Q4 2024.